{"transactions":[{"id":5995,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-11T00:24:08.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":85.1685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 460 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7485.9046,"source":{"system":"sec-edgar","filing":"0000318154-26-000133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000133/form4.xml","form_type":"4"}},{"id":9557,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T23:02:52.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 418 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":7358.7361,"source":{"system":"sec-edgar","filing":"0000318154-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000104/form4.xml","form_type":"4"}},{"id":10070,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-08T00:40:36.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":106.1925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 418 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount."}],"balance_after":6693.7361,"source":{"system":"sec-edgar","filing":"0000318154-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000071/form4.xml","form_type":"4"}},{"id":17357,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-13T00:33:16.000Z","date":"2025-11-07","kind":"grant","planned":false,"acquired":true,"shares":218.6134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 338 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":6507.5436,"source":{"system":"sec-edgar","filing":"0000318154-25-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000079/form4.xml","form_type":"4"}},{"id":20907,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-12T23:27:28.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":121.4308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 291 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":6241.9302,"source":{"system":"sec-edgar","filing":"0000318154-25-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815425000061/form4.xml","form_type":"4"}},{"id":23555,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-29T01:04:28.000Z","date":"2025-05-23","kind":"grant","planned":false,"acquired":true,"shares":809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 255 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":6084.4994,"source":{"system":"sec-edgar","filing":"0001127602-25-015857","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225015857/form4.xml","form_type":"4"}},{"id":24240,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-09T00:13:13.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":129.4187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 255 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":5275.4994,"source":{"system":"sec-edgar","filing":"0001127602-25-013770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760225013770/form4.xml","form_type":"4"}},{"id":25309,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2025-04-01T20:27:51.000Z","date":"2025-03-28","kind":"grant","planned":false,"acquired":true,"shares":1376.046,"price":22.71,"value":31250.00466,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit represents the right to receive the cash value of one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."}],"balance_after":5838.215,"derivative":{"underlying":"Common Stock","underlying_shares":1376.046},"source":{"system":"sec-edgar","filing":"0001127602-25-010793","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760225010793/form4.xml","form_type":"4"}},{"id":30973,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2024-12-31T21:11:20.000Z","date":"2024-12-27","kind":"grant","planned":false,"acquired":true,"shares":1539.409,"price":20.3,"value":31250.0027,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit represents the right to receive the cash value of one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."}],"balance_after":4462.169,"derivative":{"underlying":"Common Stock","underlying_shares":1539.409},"source":{"system":"sec-edgar","filing":"0001127602-24-030212","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760224030212/form4.xml","form_type":"4"}},{"id":34153,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-07T00:41:03.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":220.8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 190 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":5081.0807,"source":{"system":"sec-edgar","filing":"0001127602-24-026625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224026625/form4.xml","form_type":"4"}},{"id":35116,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2024-10-01T21:07:01.000Z","date":"2024-09-27","kind":"grant","planned":false,"acquired":true,"shares":1306.985,"price":23.91,"value":31250.01135,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit represents the right to receive the cash value of one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9.986 units acquired via dividend reinvestment in September 2024."}],"balance_after":2922.76,"derivative":{"underlying":"Common Stock","underlying_shares":1306.985},"source":{"system":"sec-edgar","filing":"0001127602-24-024724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760224024724/form4.xml","form_type":"4"}},{"id":37012,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-13T21:44:36.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":108.5305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 163 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":4833.1978,"source":{"system":"sec-edgar","filing":"0001127602-24-022108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224022108/form4.xml","form_type":"4"}},{"id":38596,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2024-07-02T20:44:01.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1009.041,"price":30.97,"value":31249.99977,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit represents the right to receive the cash value of one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2.453 units acquired via dividend reinvestment in June 2024."}],"balance_after":1605.789,"derivative":{"underlying":"Common Stock","underlying_shares":1009.041},"source":{"system":"sec-edgar","filing":"0001127602-24-019900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760224019900/form4.xml","form_type":"4"}},{"id":40125,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-04T23:29:06.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 134 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":4695.6673,"source":{"system":"sec-edgar","filing":"0001127602-24-017811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224017811/form4.xml","form_type":"4"}},{"id":41028,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-10T20:18:03.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":7403,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2025 Annual Stockholders' Meeting."}],"balance_after":7403,"derivative":{"underlying":"Common Stock","underlying_shares":7403},"source":{"system":"sec-edgar","filing":"0001127602-24-014992","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760224014992/form4.xml","form_type":"4"}},{"id":41142,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-08T23:58:23.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":116.5501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 134 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":3976.6673,"source":{"system":"sec-edgar","filing":"0001127602-24-014686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760224014686/form4.xml","form_type":"4"}},{"id":42161,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2024-04-02T20:38:05.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":594.295,"price":44.17,"value":26250.01015,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit represents the right to receive the cash value of one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are payable in cash following termination of the reporting person's service on the board of directors."}],"balance_after":594.295,"derivative":{"underlying":"Common Stock","underlying_shares":594.295},"source":{"system":"sec-edgar","filing":"0001127602-24-011841","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760224011841/form4.xml","form_type":"4"}},{"id":51508,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-08T01:10:24.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":240.8656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 87 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":3813.1172,"source":{"system":"sec-edgar","filing":"0001127602-23-026974","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223026974/form4.xml","form_type":"4"}},{"id":1755140,"issuer":{"id":8577,"kind":"organization","name":"ALLURION TECHNOLOGIES, INC."},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-25T20:53:30.000Z","date":"2023-10-23","kind":"grant","planned":false,"acquired":true,"shares":45235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent an initial, one-time grant of Restricted Stock Units (\"RSUs\") issued pursuant to the Issuer's non-employee director compensation policy and the Allurion Technologies, Inc. 2023 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in equal annual installments over three years from October 23, 2023, subject to the Reporting Person's continued service as a director of the Issuer on each such vesting date."}],"balance_after":45235,"source":{"system":"sec-edgar","filing":"0000950170-23-055251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000095017023055251/ownership.xml","form_type":"4"}},{"id":53745,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-11T00:56:23.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":124.6166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":3525.2516,"source":{"system":"sec-edgar","filing":"0001127602-23-022310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223022310/form4.xml","form_type":"4"}},{"id":53747,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-10T22:18:59.000Z","date":"2023-01-30","kind":"purchase","planned":false,"acquired":true,"shares":86,"price":28.0471,"value":2412.0506,"ownership":{"direct":false,"nature":"By Family Trust"},"balance_after":86,"source":{"system":"sec-edgar","filing":"0001127602-23-022303","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760223022303/form4.xml","form_type":"4"}},{"id":1817191,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110912,"kind":"person","name":"Compute Health Sponsor LLC","position":1,"cik":"0001828596","reported_name":"Compute Health Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-08-03T20:26:26.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21442500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":21442500},"source":{"system":"sec-edgar","filing":"0001209191-23-044553","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044553/doc4a.xml","form_type":"4/A","original_submission_date":"2023-08-03"}},{"id":1817190,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110912,"kind":"person","name":"Compute Health Sponsor LLC","position":1,"cik":"0001828596","reported_name":"Compute Health Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T20:26:26.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1926948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the terms of the Business Combination Agreement, each of the 1,926,948 shares of Class A Common Stock held by the Sponsor were canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Business Combination Agreement, each of the 1,926,948 shares of Class A Common Stock held by the Sponsor were canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-044553","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044553/doc4a.xml","form_type":"4/A","original_submission_date":"2023-08-03"}},{"id":1817189,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110912,"kind":"person","name":"Compute Health Sponsor LLC","position":1,"cik":"0001828596","reported_name":"Compute Health Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T20:26:26.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":161379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of that certain Contribution Agreement, dated as of May 2, 2023, by and between the issuer and the Sponsor, 161,379 shares of Class A Common Stock held by the Sponsor were contributed to the capital of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of that certain Contribution Agreement, dated as of May 2, 2023, by and between the issuer and the Sponsor, 161,379 shares of Class A Common Stock held by the Sponsor were contributed to the capital of the issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":1926948,"source":{"system":"sec-edgar","filing":"0001209191-23-044553","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044553/doc4a.xml","form_type":"4/A","original_submission_date":"2023-08-03"}},{"id":1817188,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110912,"kind":"person","name":"Compute Health Sponsor LLC","position":1,"cik":"0001828596","reported_name":"Compute Health Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T20:26:26.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":2088327,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":2088327,"source":{"system":"sec-edgar","filing":"0001209191-23-044553","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044553/doc4a.xml","form_type":"4/A","original_submission_date":"2023-08-03"}},{"id":1817180,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110908,"kind":"person","name":"Compute Health Sponsor II LLC","position":1,"cik":"0001857472","reported_name":"Compute Health Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-08-03T16:38:49.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21442500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-252245) under the heading \"Description of Securities--Founder Shares,\" the shares of Class B Common Stock were to automatically convert into shares of Class A Common Stock at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":21442500},"source":{"system":"sec-edgar","filing":"0001209191-23-044453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044453/doc4.xml","form_type":"4"}},{"id":1817179,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110908,"kind":"person","name":"Compute Health Sponsor II LLC","position":1,"cik":"0001857472","reported_name":"Compute Health Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T16:38:49.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1926948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the terms of the Business Combination Agreement, each of the 1,926,948 shares of Class A Common Stock held by the Sponsor were canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the terms of the Business Combination Agreement, each of the 1,926,948 shares of Class A Common Stock held by the Sponsor were canceled and converted into the right to receive 1.420455 shares of Pubco common stock, $0.0001 par value."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-044453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044453/doc4.xml","form_type":"4"}},{"id":1817178,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110908,"kind":"person","name":"Compute Health Sponsor II LLC","position":1,"cik":"0001857472","reported_name":"Compute Health Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T16:38:49.000Z","date":"2023-08-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":161379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of that certain Contribution Agreement, dated as of May 2, 2023, by and between the issuer and the Sponsor, 161,379 shares of Class A Common Stock held by the Sponsor were contributed to the capital of the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of that certain Contribution Agreement, dated as of May 2, 2023, by and between the issuer and the Sponsor, 161,379 shares of Class A Common Stock held by the Sponsor were contributed to the capital of the issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":1926948,"source":{"system":"sec-edgar","filing":"0001209191-23-044453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044453/doc4.xml","form_type":"4"}},{"id":1817177,"issuer":{"id":110906,"kind":"organization","name":"Compute Health Acquisition Corp.","symbol":"CPUH"},"owners":[{"id":110908,"kind":"person","name":"Compute Health Sponsor II LLC","position":1,"cik":"0001857472","reported_name":"Compute Health Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":2,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110909,"kind":"person","name":"Nehme Jean","position":3,"cik":"0001843660","reported_name":"Nehme Jean","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110910,"kind":"person","name":"Fink Joshua A","position":4,"cik":"0001414107","reported_name":"Fink Joshua A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-08-03T16:38:49.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":2088327,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects transactions in connection with that certain Business Combination Agreement (the \"Business Combination Agreement\"), dated as of February 9, 2023 and amended as of May 2, 2023, by and among the issuer, Allurion Technologies Opco, Inc. (f/k/a Allurion Technologies, Inc.) (\"Allurion\"), Allurion Technologies, Inc. (f/k/a Allurion Technologies Holdings, Inc.) (\"Pubco\") and the other parties thereto (the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the conversion of the issuer's Class B common stock, par value $0.0001 (\"Class B Common Stock\"), and 12,833,333 warrants acquired from the issuer in connection with the issuer's initial public offering into 2,088,327 shares of the issuer's Class A common stock, par value $0.0001 (\"Class A Common Stock\"), pursuant to the terms of that certain Sponsor Support Agreement, dated as of February 9, 2023, entered into by and among the issuer, Compute Health Sponsor LLC (the \"Sponsor\"), Allurion, Pubco and the other parties thereto, which was entered into in connection with the Business Combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are held in the name of the Sponsor, which is managed by its managing members, Omar Ishrak, Jean Nehme and Joshua Fink. Each of the Reporting Persons may be deemed a beneficial owner of securities held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such securities except to the extent of its respective pecuniary interest therein."}],"balance_after":2088327,"source":{"system":"sec-edgar","filing":"0001209191-23-044453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828608/000120919123044453/doc4.xml","form_type":"4"}},{"id":55627,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-23T23:24:06.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":3400.635,"source":{"system":"sec-edgar","filing":"0001127602-23-016637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223016637/form4.xml","form_type":"4"}},{"id":55974,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-15T22:08:43.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":false,"shares":4828,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4828},"source":{"system":"sec-edgar","filing":"0001127602-23-015607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760223015607/form4.xml","form_type":"4"}},{"id":55973,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-15T22:08:43.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":7152,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person elected to defer settlement of their grant of restricted stock units until the termination of their service to the Intel Corporation Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2024 Annual Stockholders' Meeting."}],"balance_after":7152,"derivative":{"underlying":"Common Stock","underlying_shares":7152},"source":{"system":"sec-edgar","filing":"0001127602-23-015607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760223015607/form4.xml","form_type":"4"}},{"id":55972,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-15T22:08:43.000Z","date":"2023-05-11","kind":"exercise","planned":false,"acquired":true,"shares":4828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."}],"balance_after":54772,"source":{"system":"sec-edgar","filing":"0001127602-23-015607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760223015607/form4.xml","form_type":"4"}},{"id":56322,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-04T00:34:01.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":137.7294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":2461.635,"source":{"system":"sec-edgar","filing":"0001127602-23-014374","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760223014374/form4.xml","form_type":"4"}},{"id":61770,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-11T02:16:11.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":222.3058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 18 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":2301.9056,"source":{"system":"sec-edgar","filing":"0001127602-22-025333","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222025333/form4.xml","form_type":"4"}},{"id":64247,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-11T21:39:26.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":130.8584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include eight Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount."}],"balance_after":2069.5998,"source":{"system":"sec-edgar","filing":"0001127602-22-020847","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222020847/form4.xml","form_type":"4"}},{"id":66065,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-20T01:54:42.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested\nRSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule."}],"balance_after":1930.7414,"source":{"system":"sec-edgar","filing":"0001127602-22-015177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222015177/form4.xml","form_type":"4"}},{"id":66322,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-16T23:27:07.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":3720,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3720},"source":{"system":"sec-edgar","filing":"0001127602-22-014676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760222014676/form4.xml","form_type":"4"}},{"id":66321,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-16T23:27:07.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":4828,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of May 12, 2023 or the date of the 2023 Annual Stockholders' Meeting."}],"balance_after":4828,"derivative":{"underlying":"Common Stock","underlying_shares":4828},"source":{"system":"sec-edgar","filing":"0001127602-22-014676","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760222014676/form4.xml","form_type":"4"}},{"id":66320,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-16T23:27:07.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":3720,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel common stock."}],"balance_after":49944,"source":{"system":"sec-edgar","filing":"0001127602-22-014676","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760222014676/form4.xml","form_type":"4"}},{"id":66668,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-04T23:40:32.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":140.7414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":1075.7414,"source":{"system":"sec-edgar","filing":"0001127602-22-013338","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760222013338/form4.xml","form_type":"4"}},{"id":70165,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-24T21:25:08.000Z","date":"2022-02-22","kind":"purchase","acquired":true,"shares":11025,"price":45.1087,"value":497323.4175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $45.075 to $45.125. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":46224,"source":{"system":"sec-edgar","filing":"0001127602-22-006568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760222006568/form4.xml","form_type":"4"}},{"id":78104,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-01T20:50:59.000Z","date":"2021-10-28","kind":"purchase","acquired":true,"shares":20000,"price":48.0209,"value":960418.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $48.01 to $48.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":35199,"source":{"system":"sec-edgar","filing":"0001127602-21-027958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221027958/form4.xml","form_type":"4"}},{"id":82925,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-08-10T22:59:09.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":935,"source":{"system":"sec-edgar","filing":"0001127602-21-023488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221023488/form4.xml","form_type":"4"}},{"id":87428,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-17T20:44:48.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":3720,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the \"Company\") common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the  RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the  RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) or the date of the 2022 Annual Stockholders' Meeting."}],"balance_after":3720,"derivative":{"underlying":"Common Stock","underlying_shares":3720},"source":{"system":"sec-edgar","filing":"0001127602-21-017048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221017048/form4.xml","form_type":"4"}},{"id":87427,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-17T20:44:48.000Z","date":"2021-05-13","kind":"exercise","acquired":false,"shares":3721,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the \"Company\") common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3721},"source":{"system":"sec-edgar","filing":"0001127602-21-017048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221017048/form4.xml","form_type":"4"}},{"id":87426,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-17T20:44:48.000Z","date":"2021-05-13","kind":"exercise","acquired":true,"shares":3721,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation (the \"Company\") common stock."}],"balance_after":15199,"source":{"system":"sec-edgar","filing":"0001127602-21-017048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221017048/form4.xml","form_type":"4"}},{"id":94428,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-02-03T01:57:11.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":810,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":810},"source":{"system":"sec-edgar","filing":"0001127602-21-003590","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221003590/form4.xml","form_type":"4"}},{"id":94427,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-03T01:57:11.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":11478,"source":{"system":"sec-edgar","filing":"0001127602-21-003590","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760221003590/form4.xml","form_type":"4"}},{"id":2948141,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-12-11T22:27:56.000Z","date":"2020-10-15","kind":"gift","acquired":true,"shares":8650,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Joint Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held in a trust for the benefit of the reporting person's children.  The reporting person's spouse and the reporting person are co-trustees of the trust.  The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":8650,"source":{"system":"sec-edgar","filing":"0001127602-20-031212","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220031212/form4.xml","form_type":"4"}},{"id":2948140,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-12-11T22:27:56.000Z","date":"2020-10-15","kind":"gift","acquired":false,"shares":8650,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2019 GRAT"},"balance_after":9532,"source":{"system":"sec-edgar","filing":"0001127602-20-031212","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220031212/form4.xml","form_type":"4"}},{"id":3006852,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-10-14T22:38:15.000Z","date":"2020-10-09","kind":"gift","acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":566932,"source":{"system":"sec-edgar","filing":"0001127602-20-026951","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220026951/form4.xml","form_type":"4"}},{"id":3006851,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-10-14T22:38:15.000Z","date":"2020-10-09","kind":"gift","acquired":false,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2018 GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-20-026951","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220026951/form4.xml","form_type":"4"}},{"id":3006850,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-10-14T22:38:15.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":763,"price":108.4,"value":82709.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price and has been rounded to two decimals.  The share were sold in multiple transactions at prices ranging from $108.395 to $108.397, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":561032,"source":{"system":"sec-edgar","filing":"0001127602-20-026951","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220026951/form4.xml","form_type":"4"}},{"id":3066917,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:55:34.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":159318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":159318,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":159318},"source":{"system":"sec-edgar","filing":"0001127602-20-022896","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220022896/form4.xml","form_type":"4"}},{"id":3071096,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:37:39.000Z","date":"2020-07-31","kind":"tax_withholding","acquired":false,"shares":26082,"price":96.48,"value":2516391.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 2,888 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan."}],"balance_after":561795,"source":{"system":"sec-edgar","filing":"0001127602-20-022589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220022589/form4.xml","form_type":"4"}},{"id":3090889,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-07-02T21:31:40.000Z","date":"2020-06-30","kind":"gift","acquired":true,"shares":22508,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2020 GRAT"},"balance_after":22508,"source":{"system":"sec-edgar","filing":"0001127602-20-021037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220021037/form4.xml","form_type":"4"}},{"id":3090888,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Ordinary Shares","published_at":"2020-07-02T21:31:40.000Z","date":"2020-06-30","kind":"gift","acquired":false,"shares":22508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 2,307 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":584989,"source":{"system":"sec-edgar","filing":"0001127602-20-021037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220021037/form4.xml","form_type":"4"}},{"id":104758,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-05-18T20:45:04.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":3721,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the first anniversary of the grant date (or next business date, if applicable) and the date of the 2021 Annual Stockholders' Meeting."}],"balance_after":3721,"derivative":{"underlying":"Common Stock","underlying_shares":3721},"source":{"system":"sec-edgar","filing":"0001127602-20-016961","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220016961/form4.xml","form_type":"4"}},{"id":104757,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-05-18T20:45:04.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":4259,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the 1st anniversary of the grant date (or next business date, if applicable) and the date of the 2020 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the 1st anniversary of the grant date (or next business date, if applicable) and the date of the 2020 Annual Stockholders' Meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4259},"source":{"system":"sec-edgar","filing":"0001127602-20-016961","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220016961/form4.xml","form_type":"4"}},{"id":104756,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-18T20:45:04.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":4259,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":10668,"source":{"system":"sec-edgar","filing":"0001127602-20-016961","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220016961/form4.xml","form_type":"4"}},{"id":106519,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Performance-based Restricted Stock Units","published_at":"2020-03-05T00:24:43.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":2697,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based Restricted Stock Unit (RSU) represents the right to receive, following vesting, up to 200% of one share of Intel common stock.  The number of shares of Intel common stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on February 1, 2017 and ending on the third anniversary of February 1, 2017, unless that date falls on a date that the NASDAQ Stock Market is closed, in which case the next business date that the NASDAQ Stock Market is open shall apply."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based Restricted Stock Unit (RSU) represents the right to receive, following vesting, up to 200% of one share of Intel common stock.  The number of shares of Intel common stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on February 1, 2017 and ending on the third anniversary of February 1, 2017, unless that date falls on a date that the NASDAQ Stock Market is closed, in which case the next business date that the NASDAQ Stock Market is open shall apply."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Intel common stock three years and one month after February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Intel common stock three years and one month after February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The total number of shares of Common Stock received upon achievement of the pre-established performance metrics was 1,819 (or 67.452% of the target number of performance-based RSUs granted), as reported in Table I."}],"balance_after":0,"derivative":{"exercise_date":"2020-03-02","underlying":"Common Stock","underlying_shares":2697},"source":{"system":"sec-edgar","filing":"0001127602-20-009507","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220009507/form4.xml","form_type":"4"}},{"id":106518,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-05T00:24:43.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":1819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance-based Restricted Stock Unit (RSU) represents the right to receive, following vesting, up to 200% of one share of Intel common stock.  The number of shares of Intel common stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on February 1, 2017 and ending on the third anniversary of February 1, 2017, unless that date falls on a date that the NASDAQ Stock Market is closed, in which case the next business date that the NASDAQ Stock Market is open shall apply."}],"balance_after":6409,"source":{"system":"sec-edgar","filing":"0001127602-20-009507","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220009507/form4.xml","form_type":"4"}},{"id":3252217,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2020-02-24T13:56:57.000Z","date":"2020-02-20","kind":"purchase","acquired":true,"shares":8771,"price":113.68,"value":997087.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $113.65 to $113.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":605190,"source":{"system":"sec-edgar","filing":"0001127602-20-007086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760220007086/form4.xml","form_type":"4"}},{"id":108681,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-02-04T00:06:24.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":845,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":845},"source":{"system":"sec-edgar","filing":"0001127602-20-003273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220003273/form4.xml","form_type":"4"}},{"id":108680,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-02-04T00:06:24.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":810,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":810,"derivative":{"underlying":"Common Stock","underlying_shares":810},"source":{"system":"sec-edgar","filing":"0001127602-20-003273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220003273/form4.xml","form_type":"4"}},{"id":108679,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-04T00:06:24.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":845,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":4590,"source":{"system":"sec-edgar","filing":"0001127602-20-003273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220003273/form4.xml","form_type":"4"}},{"id":108678,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-04T00:06:24.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":3745,"source":{"system":"sec-edgar","filing":"0001127602-20-003273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760220003273/form4.xml","form_type":"4"}},{"id":3343422,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-12-12T22:44:16.000Z","date":"2019-12-03","kind":"gift","acquired":true,"shares":18182,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2019 GRAT"},"balance_after":18182,"source":{"system":"sec-edgar","filing":"0001127602-19-034887","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219034887/form4.xml","form_type":"4"}},{"id":3343421,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-12-12T22:44:16.000Z","date":"2019-12-03","kind":"gift","acquired":false,"shares":18182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 2,184 shares due to exempt transactions such as dividend reinvestment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,615 shares previously reported as owned indirectly through the 2017 GRAT."}],"balance_after":594425,"source":{"system":"sec-edgar","filing":"0001127602-19-034887","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219034887/form4.xml","form_type":"4"}},{"id":3395108,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-10-09T22:22:54.000Z","date":"2019-10-07","kind":"gift","acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":602808,"source":{"system":"sec-edgar","filing":"0001127602-19-030330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219030330/form4.xml","form_type":"4"}},{"id":3395107,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-10-09T22:22:54.000Z","date":"2019-10-07","kind":"gift","acquired":false,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2018 GRAT"},"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001127602-19-030330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219030330/form4.xml","form_type":"4"}},{"id":3448792,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-08-02T22:25:54.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":24894,"price":102.37,"value":2548398.78,"ownership":{"direct":true},"balance_after":598708,"source":{"system":"sec-edgar","filing":"0001127602-19-025931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219025931/form4.xml","form_type":"4"}},{"id":3451768,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T21:53:45.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":301440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":301440,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":301440},"source":{"system":"sec-edgar","filing":"0001127602-19-025554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219025554/form4.xml","form_type":"4"}},{"id":3451767,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-07-31T21:53:45.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":45194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 7,686 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan."}],"balance_after":623602,"source":{"system":"sec-edgar","filing":"0001127602-19-025554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219025554/form4.xml","form_type":"4"}},{"id":116526,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-05-20T22:34:26.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":4259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the 1st anniversary of the grant date (or next business date, if applicable) and the date of the 2020 Annual Stockholders' Meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the award, 100% of the RSUs vest and convert into common stock on the earlier of the 1st anniversary of the grant date (or next business date, if applicable) and the date of the 2020 Annual Stockholders' Meeting."}],"balance_after":4259,"derivative":{"underlying":"Common Stock","underlying_shares":4259},"source":{"system":"sec-edgar","filing":"0001127602-19-019215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760219019215/form4.xml","form_type":"4"}},{"id":120539,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-02-05T21:14:46.000Z","date":"2019-02-01","kind":"exercise","acquired":false,"shares":844,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":845,"derivative":{"exercise_date":"2018-02-01","underlying":"Common Stock","underlying_shares":844},"source":{"system":"sec-edgar","filing":"0001127602-19-004053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760219004053/form4.xml","form_type":"4"}},{"id":120538,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-05T21:14:46.000Z","date":"2019-02-01","kind":"exercise","acquired":true,"shares":844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":2935,"source":{"system":"sec-edgar","filing":"0001127602-19-004053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760219004053/form4.xml","form_type":"4"}},{"id":120747,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-02-01T21:47:08.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":811,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":1620,"derivative":{"exercise_date":"2019-01-30","underlying":"Common Stock","underlying_shares":811},"source":{"system":"sec-edgar","filing":"0001127602-19-003392","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760219003392/form4.xml","form_type":"4"}},{"id":120746,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-01T21:47:08.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":811,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."}],"balance_after":2091,"source":{"system":"sec-edgar","filing":"0001127602-19-003392","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760219003392/form4.xml","form_type":"4"}},{"id":3698820,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2019-01-09T17:27:01.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":12000,"price":84.045,"value":1008540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.5 to $84.77, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 2,326 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":570722,"source":{"system":"sec-edgar","filing":"0001127602-19-001695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760219001695/form4.xml","form_type":"4"}},{"id":3814001,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-17T22:06:03.000Z","date":"2018-09-14","kind":"gift","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"2018 GRAT"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001127602-18-027799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218027799/form4.xml","form_type":"4"}},{"id":3814000,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-17T22:06:03.000Z","date":"2018-09-14","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":556396,"source":{"system":"sec-edgar","filing":"0001127602-18-027799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218027799/form4.xml","form_type":"4"}},{"id":3820384,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-10T20:35:32.000Z","date":"2018-09-07","kind":"gift","acquired":true,"shares":4580,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":566396,"source":{"system":"sec-edgar","filing":"0001127602-18-027247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218027247/form4.xml","form_type":"4"}},{"id":3820383,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-10T20:35:32.000Z","date":"2018-09-07","kind":"gift","acquired":false,"shares":4580,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GRAT"},"balance_after":7615,"source":{"system":"sec-edgar","filing":"0001127602-18-027247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218027247/form4.xml","form_type":"4"}},{"id":3850595,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-07T20:32:54.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":27010,"price":90.48,"value":2443864.8,"ownership":{"direct":true},"balance_after":561816,"source":{"system":"sec-edgar","filing":"0001127602-18-024845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218024845/form4.xml","form_type":"4"}},{"id":3856495,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T19:48:30.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":305018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":305018,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":305018},"source":{"system":"sec-edgar","filing":"0001127602-18-024241","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218024241/form4.xml","form_type":"4"}},{"id":3856494,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-01T19:48:30.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":50517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This balance increased by 10,213 shares due to exempt transactions such as dividend reinvestment."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":588826,"source":{"system":"sec-edgar","filing":"0001127602-18-024241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760218024241/form4.xml","form_type":"4"}},{"id":132972,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-02-06T01:51:09.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of February 1, 2017, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":1689,"derivative":{"exercise_price":0,"exercise_date":"2018-02-01","underlying":"Common Stock","underlying_shares":845},"source":{"system":"sec-edgar","filing":"0001127602-18-004159","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760218004159/form4.xml","form_type":"4"}},{"id":132971,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-02-06T01:51:09.000Z","date":"2018-01-30","kind":"grant","acquired":true,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Unless earlier forfeited under the terms of the RSU, 33 1/3% of the awards vest and convert into common stock on each anniversary of the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":2431,"derivative":{"exercise_price":0,"exercise_date":"2019-01-30","underlying":"Common Stock","underlying_shares":2431},"source":{"system":"sec-edgar","filing":"0001127602-18-004159","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760218004159/form4.xml","form_type":"4"}},{"id":132970,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Performance-based Restricted Stock Units","published_at":"2018-02-06T01:51:09.000Z","date":"2018-01-30","kind":"grant","acquired":true,"shares":2102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance-based Restricted Stock Unit (RSU) represents the right to receive, following vesting, up to 200% of one share of Intel common stock. The number of shares of Intel common stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the grant date and ending on the third anniversary of the grant date, unless that date falls on a date that the NASDAQ Stock Market is closed, in which case the next business date that the NASDAQ Stock Market is open shall apply."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Intel common stock three years and one month after the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Unless earlier forfeited under the terms of the performance-based RSU, each performance-based RSU vests and converts into no more than 200% of one share of Intel common stock three years and one month after the grant date, unless that date falls on a non-business date, in which case the next business date shall apply."}],"balance_after":2102,"derivative":{"exercise_price":0,"exercise_date":"2021-02-28","underlying":"Common Stock","underlying_shares":2102},"source":{"system":"sec-edgar","filing":"0001127602-18-004159","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760218004159/form4.xml","form_type":"4"}},{"id":132969,"issuer":{"id":2799,"kind":"organization","name":"INTEL CORP"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-02-06T01:51:09.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired on the vesting of restricted stock units."}],"balance_after":1280,"source":{"system":"sec-edgar","filing":"0001127602-18-004159","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/50863/000112760218004159/form4.xml","form_type":"4"}},{"id":4206902,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-18T23:11:04.000Z","date":"2017-09-15","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 290,338 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 290,338 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":115338,"derivative":{"exercise_price":38.81,"expiration_date":"2022-07-30","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-17-027649","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217027649/form4.xml","form_type":"4"}},{"id":4206901,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-09-18T23:11:04.000Z","date":"2017-09-15","kind":"sale","acquired":false,"shares":140407,"price":81.63,"value":11461423.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $81.464 to $81.941, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":528096,"source":{"system":"sec-edgar","filing":"0001127602-17-027649","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217027649/form4.xml","form_type":"4"}},{"id":4206900,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-09-18T23:11:04.000Z","date":"2017-09-15","kind":"exercise","acquired":true,"shares":100000,"price":38.81,"value":3881000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":668503,"source":{"system":"sec-edgar","filing":"0001127602-17-027649","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217027649/form4.xml","form_type":"4"}},{"id":4224324,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-08-25T21:01:07.000Z","date":"2017-08-23","kind":"gift","acquired":true,"shares":12195,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GRAT"},"balance_after":12195,"source":{"system":"sec-edgar","filing":"0001127602-17-026511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217026511/form4.xml","form_type":"4"}},{"id":4224323,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-08-25T21:01:07.000Z","date":"2017-08-23","kind":"gift","acquired":false,"shares":12195,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":568503,"source":{"system":"sec-edgar","filing":"0001127602-17-026511","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217026511/form4.xml","form_type":"4"}},{"id":4245320,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T19:03:04.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":214363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":214363,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":214363},"source":{"system":"sec-edgar","filing":"0001127602-17-024714","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217024714/form4.xml","form_type":"4"}},{"id":4245319,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-08-02T19:03:04.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":53591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":580698,"source":{"system":"sec-edgar","filing":"0001127602-17-024714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217024714/form4.xml","form_type":"4"}},{"id":4247034,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":10488,"kind":"person","name":"ISHRAK OMAR","position":1,"cik":"0001523102","reported_name":"ISHRAK OMAR","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2017-08-01T16:38:30.000Z","date":"2017-07-28","kind":"tax_withholding","acquired":false,"shares":28522,"price":84.29,"value":2404119.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 5013 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":527107,"source":{"system":"sec-edgar","filing":"0001127602-17-024467","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1523102/000112760217024467/form4.xml","form_type":"4"}}],"next_cursor":"2017-08-01T16:38:30.000000Z,4247034"}